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In rodents, kisspeptin expressing neurons are localized in two hypothalamic brain nuclei [antero-
ventral periventricular nucleus/periventricular nucleus continuum (AVPv/PeN) andarcuate nucleus
(ARC)] and modulated by sex steroids. By using wild-type (WT) and aromatase knockout mice
(ArKO,which cannot convert testosterone intoestradiol) and immunohistochemistry,weobserved
that WT females showed a continuous increase in kisspeptin peptide expression in the ARC across
postnatal ages (P5 to P25), whereas WTmales did not show any expression before P25. Kisspeptin
peptide expressionwas also present in ArKO females but did not increase over this early postnatal
period, suggesting that kisspeptin peptide expression in the ARC is organized by estradiol-depen-
dent and –independent mechanisms. We also compared kisspeptin peptide expression between
groups of adult male and female mice which were left gonadally intact or gonadectomized and
treated or not with estradiol (E2) or dihydrotestosterone (DHT). In the ARC, kisspeptin peptide
expression decreased after gonadectomy but was completely rescued by either E2 or DHT treat-
ment in each sex/genotype. However, kisspeptin peptide expression was lower in ArKO compared
to WT subjects. In the AVPv/PeN, ArKO females showed a male-typical kisspeptin peptide expres-
sion, and adult E2 treatment partially restored kisspeptin peptide expression. Finally, we showed
that, after E2 treatmentofWTandArKOmicebetweeneither P5 andP15or P15 andP25,AVPv/PeN
kisspeptin peptide expression could be still masculinized at P5, but was feminized from P15 on-
wards. In conclusion, the two kisspeptin neuronal populations (AVPv/PeN versus ARC) seem to be
differentially organized and activated by E2.
Kisspeptin is the processed peptide product of theKiss1gene and the endogenous agonist for the Gpr54 re-
ceptor. Over the last eight years, the role of kisspeptin in
reproductive maturation and function has been further
refined by including its participation in the sexual differ-
entiation of the brain (1, 2), puberty onset (3), feedback
regulation of gonadotropin secretion (4), neuroendocrine
control of ovulation (5), metabolic modulation of fertility
(6), as well as the environmental (photoperiod) control of
reproduction in seasonal species (7). Furthermore, all
these studies have highlighted a conserved and prominent
populationof kisspeptin expressingneurons in the arcuate
nucleus (ARC) (1, 4, 8) and a second population in the
anteroventral periventricular nucleus/periventricular nu-
cleus continuum (AVPv/PeN (9-11)) in rodents. There is
ample evidence showing that the kisspeptin neuronal pop-
ulation in the AVPv/PeN is sexually dimorphic in rodents
(8, 9) with adult females having more kisspeptin express-
ing neurons than adult males.
In recent years, many signals have been identified as
putative modulators of the hypothalamic kisspeptin sys-
tem. Among them, the prominent role of sex steroids (es-
trogens, androgens and progestins) as being important
regulators of kisspeptin expression has been described in
different species and at various life stages such as during
embryonic and peripubertal periods (2, 3, 12-14) and in
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adulthood (10, 11). Indeed, kisspeptin expressing neurons
have been proven sensitive to both the early organizing
effects as well as the acute regulatory actions of sex ste-
roids; in addition, the regulatory effects of sex steroids are
population specific since theARCand theAVPv/PeNpop-
ulations of kisspeptin expressing neurons have been
shown to respond to sex steroids in a completely opposite
manner (10, 11). In adult mice,Kiss1mRNA in the AVPv/
PeN is robustly increased by estradiol (E2), and strongly
decreased by gonadectomy, in female as well as in male
rodents (2, 8, 10, 11). Testosterone (T) can also increase
kisspeptin expression in the AVPv/PeN of mice, but non-
aromatizable androgens, such as dihydrotestosterone
(DHT) have no effect, suggesting that the stimulatory ef-
fects of T are due to aromatization to E2 (11). Further-
more, almost all kisspeptin expressing neurons express
estrogen receptor alpha (ER) providing evidence of a
direct pathway bywhich E2 could stimulate these neurons
and thus participate in the positive-feedback actions of E2
to generate the preovulatory surge of gonadotrophins
(15). In contrast to the AVPv/PeN population, the kiss-
peptin neuronal population asmeasured by the number of
Kiss1 mRNA expressing neurons in the ARC is strongly
decreased by E2, and robustly increased by gonadectomy,
inboth sexes (10, 11).T canalsodecrease the total amount
of Kiss1 mRNA in the ARC, and unlike the AVPv/PeN,
some of these effects can be mediated via androgen recep-
tors sinceDHT is also able to decreaseKiss1mRNA levels
(11). Based on the ability of E2, T and DHT to inhibit
kisspeptin expression in theARC, itwas proposed that the
ARCkisspeptin populationmight be important in the neg-
ative-feedback actions of E2 on gonadotropin secretion.
During the last fewyears, studies focused essentially on the
characterization of the development of the rodent AVPv/
PeN and ARC kisspeptin systems (for review, see (16)). It
has been shown that during development, females had
significantly more Kiss1 mRNA and kisspeptin immuno-
reactivity (Kisspeptin-ir) in theAVPv/PeN thanmales, and
that this sex difference was organized by gonadal hor-
mones (1, 2, 13, 17-20). Unlike the AVPv/PeN, Kiss1
mRNA and Kisspeptin-ir can be detected in the rodent
ARC prenatally (21) and at birth (22-24) in both sexes.
InitialmRNAdata obtained in the rat suggested thatKiss1
mRNAexpression in theARCwasnot sexually dimorphic
and appeared to be insensitive to the effects of early ex-
posure to sex steroids (2); however, more recent studies,
using in situ hybridization and immunohistochemistry,
showed that the ARC kisspeptin population is likely to be
sexually dimorphic aswell, with higher numbers in female
rats after birth (23, 24) but not during embryonic life (21).
With regard to all these studies, most observations on
the regulation of neuronal kisspeptin populations were
derived from in situ hybridization experiments. However,
showing that Kiss1mRNA is present and specifically reg-
ulated in a specific nucleus does not mean that the derived
protein will be also secreted and will follow the same reg-
ulation pattern (25-27). We thus studied here by immu-
nohistochemical studies the expression and the regulation
by sex steroids (E2, T and DHT) of kisspeptin expressing
neurons in the AVPv/PeN and the ARC during early post-
natal development and in adulthood. We also used the
aromatase knockout (ArKO) mouse model, which carries
a targeted mutation in the aromatase gene and as a result
cannot convert T into E2, to determine the potential or-
ganizational role of E2 on the development of the two
different neuronal kisspeptin populations. These trans-
genicmice still have functional estrogen receptors and thus
allow us to determine the potential organizational and/or
activational role of E2 on kisspeptin expressing neurons
followinganexogenous treatmentwithE2during the early
postnatal period and/or in adulthood. In a previous study
(28), we showed that an estrogenic treatment during an
early postnatal (P5-P15) or a prepubertal (P15-P25) pe-
riod respectively defeminized or feminized the expression
of different reproductive behaviors in WT and ArKO fe-
male mice. Since the kisspeptin system is strongly related
to reproduction and modulated by E2, we determined in
the present studywhether these estrogenic treatments also
affected the organization of the kisspeptin system itself.
Clarkson and colleagues (3) previously showed that re-
placement of E2 in P15-ovariectomizedmice from P15-30
or P22-30 resulted in a complete restoration of kisspeptin
peptide expression in the AVPv/PeN of P30 mice suggest-
ing that E2 was essential for the prepubertal expression of
kisspeptin in the AVPv/PeN.
Materials and Methods
Animals
ArKOmice were generated by targeted disruption of exons 1
and 2 of the Cyp 19 gene (29). Heterozygous males and females
of the C57BL/6J strain were bred to generate wild-type (WT),
heterozygous, and homozygous-null (ArKO) offspring at the
GIGANeurosciences, University of Liège, Belgium. Food (“phy-
toestrogen-free” mouse chow D10001 AIN-76A, Brogaarden,
Denmark) and water were available to mice ad libitum. All an-
imals were housed under a 12h light: 12h dark cycle (lights on
between 8:00 and 20:00h).
All experiments were conducted in accordance with the
guidelines set forth by the National Institutes of Health “Guide
for the Care and Use of Research Animals, Eight Edition”, and
were approved by the Ethical Committee for Animal Use of the
University of Liege.
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Experiment 1: Kisspeptin peptide expression
during early postnatal development
To obtain brain tissues at early postnatal ages, pregnant fe-
males were checked daily for parturition towards the end of
pregnancy. The day of birthwas designated as P0 and all subjects
were left gonadally intact. Brain tissues were collected on P5,
P10, P15, P20 and P25. Postnatal mice were decapitated where-
upon brains were rapidly removed from the skull and immedi-
ately immersion-fixed in5%acrolein in0.1Mphosphate-buffer-
saline (PBS; pH 7.6) for 2.5h, rinsed twice in PBS for 30min and
then cryoprotected in 30% sucrose and when sunken, frozen on
dry ice and stored at –80°C until being processed for kisspeptin
immunohistochemistry. To determine the sex and the genotype
of the pup, the tail was kept and stored at –20°C for later PCR
analysis of DNA. For each age, six animals were used per sex/
genotype condition.
Experiment 2: Kisspeptin peptide expression in
adulthood
Wild-type and ArKO mice were weaned at 21 d and group-
housed until 3moof age. Subjectswere then either left gonadally
intact (Int) or gonadectomized (Ovx - Gdx) and received (during
10 d) s.c. in the neck at the time of surgery a 5-mm-long Silastic
capsule (inner diameter: 1.57 mm; outer diameter: 2.41 mm)
containing either crystalline 17-estradiol (diluted 1:1with cho-
lesterol; Ovx-Gdx/E2 10d) or crystalline DHT (Ovx-Gdx/DHT)
(supplemental Figure 1). Gonadectomy was performed as pre-
viously described (30). Groups of gonadectomized subjects were
also left either three or six weeks (Gdx 3w; Ovx 3w versus Ovx
6w) undisturbed before brain collection (see supplemental Fig-
ure 1). The dose of E2 (E8875, Sigma) was based on a previous
study (for details, see (31)) showing that this treatment leads to
proestrous levels of E2. The dose of DHT has been previously
shown to produce significant androgenic actions at the target
tissues, e.g., spermatogenesis in gonadotropin-deficient mice
(32). In previous experiments (17, 33), we observed that adult
treatment with a low dose of E2 during a short period only led to
a slight increase of AVPv/PeN kisspeptin population in ArKO
females whereas this specific neuronal population was com-
pletely absent innontreatedadultArKOfemalemice (3). Inorder
to determine the short term versus the long term effects of an E2
treatment on neural kisspeptin expression in adulthood, we
added a group of ovariectomized females (WT and ArKO) im-
planted with an E2 capsule during six weeks (Ovx/E2 6w). Male
subjectswere not exposed to E2 formore than 10 d (Gdx/E2 10d)
since their health deteriorates rapidlywhen exposed to such high
E2 concentrations.
Experiment 3: Kisspeptin peptide expression
following early postnatal or prepubertal hormonal
treatment
A first cohort of WT females was injected s.c. between the
early postnatal ages of P5-P15 with either estradiol-benzoate
(EB, E8515, Sigma) (0.5 g every 2 d) or sesame oil (S3547,
Sigma). This specific EB treatment led to a defeminization of
sexual behaviors in WT female mice (28). Females were then
ovariectomized in adulthood and treated with EB (1 g every
day) two weeks prior to sacrifice (see supplemental Figure 1). A
second cohort ofWT and ArKOmice of both sexes was injected
s.c. between theprepubertal agesofP15-P25with eitherEB (0.05
g every day) or sesame oil. This speficic EB treatment led to a
feminization of sexual behaviors in ArKO female mice (28). An-
imals were gonadectomized in adulthood and then treated with
EB (1 g every day) two weeks prior to sacrifice. Brains were
collected as described above. The number of animals used for
each group in each experiment is summarized in supplemental
Table 1.
Immunohistochemistry
Brain sections (30 m thick) were cut on a Leica CM3050S
cryostat. Forebrains were cut coronally from the rostral telen-
cephalon to the posterior hypothalamus. Sections were saved in
four different series, placed in antifreeze solution, and stored at
–20°C for later immunohistochemistry.
Every effort was made to include an equal number of brains
from all experimental conditions in each immunohistochemistry
run. Kisspeptin immunohistochemistry was carried out on free-
floating sections (for a detailed protocol, see (33)). We used a
rabbit polyclonal antibody (48h incubation - 1/5000 in TBST-
NGS 5%; Anti-Kisspeptin antibody, AB9754, Chemicon, Mil-
lipore) against the decapeptide Kisspeptin-10 (derived from the
Kiss-1 gene product). The final reaction used 3,3diaminoben-
zidine tetrahydrochloride (DAB Kit, Vector Laboratory). Sec-
tions were then washed, mounted onto slides, dried overnight,
left in xylene (Sigma) for 15min and coverslipped using Eukit
(Fluka, Steinheim, Germany).
Data analysis
An experimenter, whowas blind to the treatment of subjects,
counted the relative amount of kisspeptin-ir in the ARC. We
analyzedkisspeptin-ir in three different parts of theARC, i.e., the
rostral, themiddle and the caudal parts. Sincewe did not observe
any statistical difference in kisspeptin-ir expression between the
three parts, we only presented here the results concerning the
middle part (Figure 45, interaural 2.10 mm, bregma 1.70 mm,
according to (34)). Brains sectionswere digitized througha video
camera and then made binary for image quantification (for a
detailed protocol, see (35)). Briefly, the total amount of kisspep-
tin-ir in the ARCwasmeasured in one entire field (objective 20X
– 720 480 pixels – area 303372m2) placed in a standardized
mannerbasedonpredefinedanatomical landmarks in the section
(respectively the top of the third ventricle and the bottom of the
anterior commissure, and right or left lateral wall of the third
ventricle and the topof themedian eminence), anddeterminedby
measuring thearea (m2) coveredby“thresholded”pixels [those
pixels with a gray level higher than a defined threshold density
(specific immunoreactive staining)]. “Threshold” was deter-
mined as a constant function of the background optical density
defined as the mean optical density three to five times the stan-
dard deviation higher than the mean background density. The
mean background density was measured in a region devoid of
kisspeptin-ir, immediately lateral to the analyzed region con-
taining kisspeptin-ir. We measured the relative amount of kiss-
peptin-ir (fibers  cell bodies) in both sides of the section and
grouped into a “total amount of kisspeptin-ir” in the ARC.
Kisspeptin-ir cells bodieswere also counted bilaterally in four
adjacent brain sections (with an interval of 120 m between
them) delimiting the anteroventral periventricular nucleus
(AVPv) and the periventricular nucleus continuum (PeN) (40X
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objective). Cell counts for both sides of each section were
summed to provide a total number of kisspeptin expressing neu-
rons comprised in the AVPv/PeN per experimental condition.
Statistics
The total amount of kisspeptin-ir in the ARC or the total
number of kisspeptin-ir cells in the AVPv/PeN was analyzed us-
ing one-, two- or three-way analysis of variance (ANOVA)
(ANOVA – Statistica 10.0) with total amount of kisspeptin-ir or
total number of kisspeptin-ir cells as the dependent measure and
age (5), sex (2), genotype (2) and/or hormonal treatment (2, 4 or
6) as independent factors.When appropriate, all ANOVAswere
followed by Fisher Least Significant Difference (LSD) post hoc
comparisons. Only significant (P  .05) effects are presented
below. Sex differences were analyzed using Student t test (P 
.05).
Results
Experiment 1: Kisspeptin peptide expression
during early postnatal development
In the ARC, we observed a clear sex difference in kiss-
peptin peptide expression: WT females showed a signifi-
cant increase in kisspeptin peptide expression across all
postnatal ages, whereas WT males did not show any sig-
nificant kisspeptin peptide expression before P25 (Figure
1). Interestingly, kisspeptin peptide expression did not in-
crease in ArKO females over this early postnatal period as
observed for WT females, whereas
ArKO males had very similar kiss-
peptin peptide expression as WT
males.
ANOVA on the relative amount
of kisspeptin-ir in the ARC showed a
significant interaction between age,
sex and genotype (F (4, 92)  3.81;
P  .007). Post hoc analysis of this
interaction indicated a strong sex
differencewithWT females showing
significantly more kisspeptin-ir than
WT males from P15 to P25 (Figure
2). Post hoc analysis also indicated a
significant genotype effect with WT
females showing significantly more
kisspeptin-ir than ArKO females at
P20 and P25, whereas kisspeptin
peptide expression was significantly
higher in ArKO males at P20 com-
pared to WT males, but this differ-
ence disappeared at P25.
In the AVPv/PeN, we found the
same pattern of kisspeptin peptide
expressionduring earlypostnatal de-
velopment than Clarkson and colleagues (1, 3) previously
described. Kisspeptin-ir cells first appeared around P15-
P20 inWT femaleswhereas theywere first detected at P25
in WT males; a significant sex difference was observed at
P25,withWT females havingmore kisspeptin-ir cells than
WT males (data not shown). No kisspeptin-ir cells were
detected in ArKOmales and females between P5 and P25.
Figure 1. Representative photomicrographs show coronal sections of the arcuate nucleus (ARC)
with kisspeptin immunoreactivity in a WT female (panels A-D), an ArKO female (panels E-H), a
WT male (panels I-L) and an ArKO male (panels M-P) across different postnatal ages [P10 (panels
A,E,I,M) – P15 (panels B,F,J,N) – P20 (panels C,G,K,O) – P25 (panels O,H,L,P)]. V  third ventricle.
Scale bar  100 m.
Figure 2. The total amount (mean  S.E.M) of kisspeptin-
immunoreactivity (-ir) in the arcuate nucleus (ARC) across the postnatal
period in male and female wild-type (WT) and aromatase knockout
(ArKO) mice. For each postnatal age, means with different superscript
letters are significantly different from each other by post hoc
comparisons (P  .05). The number of subjects in each group is given
in parentheses.
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Experiment 2: Kisspeptin peptide expression in
adulthood
In the ARC, in contrast with the early postnatal period,
no difference was observed in kisspeptin-ir between intact
WT males and females. However, ArKO mice of both
sexes had lower kisspeptin-ir in this brain region. In con-
trast with previous results on Kiss1 mRNA levels (for re-
view, see (10, 11, 36)) gonadectomy decreased signifi-
cantly kisspeptin peptide expression in the ARC of both
sexes, with the exception of ArKO females, whereas treat-
ment with either E2 (10 d) or DHT increased kisspeptin
peptide expression up to levels observed in WT intact an-
imals. However, E2 treatment (6 wk) totally suppressed
kisspeptin peptide expression in ovariectomized WT and
ArKO females.
ANOVA on kisspeptin-ir in the ARC showed a signif-
icant interaction between hormonal treatment and geno-
type in females (F (5, 42)  3.79; P  .006) and a signif-
icant effect of hormonal treatment in males (F (3, 30) 
15.18; P  .001). Post hoc analysis revealed that WT fe-
males showed significantly more kisspeptin-ir compared
to ArKO females (Figure 3). However, when treated with
E2 (10 d) orDHTArKO females showedWT-like levels of
kisspeptin-ir. In WT and ArKO males, post hoc analysis
revealed that castratedanimals showed significantly lower
levels of kisspeptin-ir, but treatment with E2 or DHT re-
stored it to WT-like levels. A T test showed that intact
females had the same level of kisspeptin-ir than intact
males in the ARC (t (10)  1.82; P  .10).
In the AVPv/PeN, intact ArKO mice of both sexes
showed a “male-typical” expression of kisspeptin in the
AVPV/PeN. Short-term (3 wk) ovariectomy had no effect
on kisspeptin peptide expression in the AVPV/PeN
whereas long-term (6wk) ovariectomy led to a very strong
decrease of the number of kisspeptin expressing neurons
(Figure 4). Inmales, gonadectomy had no effect regardless
of the genotype. Short-term treatment (10 d) with E2, but
not with DHT, increased kisspeptin peptide expression in
the AVPV/PeN of ovariectomizedWT females and ArKO
mice of both sexes, but not in gonadectomizedWTmales,
compared to intact subjects. However, kisspeptin peptide
expression remained lower in ArKO mice of both sexes
compared to WT females. When E2 treatment was pro-
longed (6 wk), kisspeptin peptide expression was still
slightly increased in the AVPv/PeN of ovariectomized
ArKO, but not WT, females. This was confirmed by
ANOVA showing a significant interaction between hor-
monal treatment and genotype in females (F (5, 43) 
3.70; P .007) and inmales (F (3, 34) 28.32; P .001)
(Figure 5). Finally, we observed the well-known sex dif-
ference in adult kisspeptin peptide expression, with intact
WT females showingmore kisspeptin-ir cells compared to
intact WT males (t (11)  5.54; P  .001).
Experiment 3: Kisspeptin peptide expression
following early postnatal and prepubertal
hormonal treatment
Treatment of WT females with EB over an early post-
natal period (P5-P15) defeminized the AVPV/PeN kiss-
peptin population in adulthood, but did not significantly
affect the ARC kisspeptin population (Figure 6). ANOVA
on the number of kisspeptin-ir cells in the AVPv/PeN re-
vealed a significant effect of treatment (F (1, 21) 41.33;
P  .001) showing that EB-treated females expressed
fewer kisspeptin-ir cells compared to oil-treated females.
ANOVA on the total amount of kisspeptin-ir in the ARC
showedno significant effect of treatment (F (1, 20)2.24;
P  .16).
Figure 3. The total amount (mean  S.E.M.) of kisspeptin-immunoreactivity (ir) in the arcuate nucleus (ARC) following gonadectomy [3 wk (3w)
versus 6 wk (6w)] and hormonal treatment with E2 [10 d (10d) versus 6 wk (6w)] or DHT in adulthood in female (left panel) and male (right panel)
wild-type (WT) and aromatase knockout (ArKO) mice. Means with different superscript letters are significantly different from each other by post
hoc comparisons (P  .05). The number of subjects in each group is given in parentheses.
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EB treatment from P15 to P25 partially restored the
AVPv/PeN kisspeptin population in ArKO females
whereas EB given over this prepubertal period had no de-
feminizing effects on the kisspeptin system inWT females
(Figure 7). This prepubertal estrogenic treatment also in-
creased the number of kisspeptin-ir cells in ArKO males.
Figure 4. Representative photomicrographs show coronal sections of anteroventral periventricular nucleus/periventricular nucleus continuum
(AVPv/PeN) with kisspeptin-immunoreactive cells in a WT female (panels A-F) and an ArKO female (panels G-L) under different hormonal treatment
[gonadally intact (panels A,G) – ovariectomized 3 wk prior sacrifice (panels B,H) – ovariectomized 6 wk prior sacrifice (panels C,I) – ovariectomized
and treated with E2 capsule during ten days prior sacrifice (panels D,J) – ovariectomized and treated with E2 capsule during 6 wk prior sacrifice
(panels E,K) – ovariectomized and treated with DHT capsule ten days prior sacrifice (panels F,L)]. Scale bar  100 m.
Figure 5. The total number (mean  S.E.M.) of kisspeptin-expressing cells in the anteroventral periventricular/rostral periventricular nucleus
(AVPv/PeN) following gonadectomy [3 wk (3w) versus 6 wk (6w)] and hormonal treatment with E2 [10 d (10d) versus 6 wk (6w)] or DHT in
adulthood in female (left panel) and male (right panel) wild-type (WT) and aromatase knockout (ArKO) mice. Means with different superscript
letters are significantly different from each other by post hoc comparisons (P  .05). The number of subjects in each group is given in parentheses.
Figure 6. (A) The total number (mean  S.E.M) of kisspeptin-ir cells in the AVPv/PeN and (B) the total amount (mean  S.E.M) of kisspeptin-ir in
the ARC in adult WT female mice treated with EB 0.5 g from P5 to P15 (every 2 d). All females were ovariectomized in adulthood and treated
with EB 1 g two weeks prior sacrifice. The number of animals in each group is given in parentheses.
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ANOVA on the number of kisspeptin-ir cells showed a
significant interaction between sex, genotype and treat-
ment (F (1, 56) 6.97; P .011). Post hoc analysis con-
firmed the well-known sex difference in adult kisspeptin
peptide expression with WT females showing more kiss-
peptin-ir cells thanWTmales. EB-treatedWT females and
males showed the same number of kisspeptin-ir cells com-
pared to oil-treated conspecifics. Finally, EB-treated
ArKO females and males showed more kisspeptin-ir cells
than oil-treated conspecifics, but still fewer compared to
WT females. In the ARC, EB treatment had no effect re-
gardless of sex or genotype (Figure 8). Thiswas confirmed
by ANOVA on the total amount of kisspeptin-ir in the
ARC showing no significant interaction between sex, ge-
notype and hormonal treatment (F (1, 55)  1.10; P 
.30).
Discussion
By using immunohistochemical methods, we determined
kisspeptin peptide expression in two specific brain nuclei
(AVPv/PeN versus ARC) throughout early postnatal de-
velopment and in adulthood in WT and ArKO mice of
both sexes. The ArKOmouse model allowed us to distin-
guish between the organizational and activational effects
of E2 on kisspeptin expression.We observed that kisspep-
tin peptide expression in the ARC versus the AVPv/PeN
were differentially organized and activated by E2.We also
found some discrepancies in the pattern of the expression
of kisspeptin protein compared to what was previously
reported for the expression ofKiss1mRNA in these brain
regions.
Effects of sex steroids on the ARC kisspeptin
system during early postnatal development
For the first time in mice, we quantified the expression
of kisspeptin protein in the ARC and showed that it was
sexually dimorphic during the early postnatal period, i.e.,
fromP10 to P25,with females showingmore kisspeptin-ir
(cell bodies plus fibers) thanmales.This sexdifference also
persisted until P30 (data not shown), whereas it was com-
pletely abolished in adulthood. In rats, a sex difference in
Figure 7. The total number (mean  S.E.M) of kisspeptin-ir cells in the AVPv/PeN in adult WT and ArKO female and male mice treated with EB
0.05 g from P15 to P25 (every day). All animals were gonadectomized in adulthood and treated with EB 1 g two weeks prior sacrifice. Means
with different superscript letters are significantly different from each other by post hoc comparisons (P  .05). The number of animals in each
group is given in parentheses.
Figure 8. The total amount (mean  S.E.M) of kisspeptin-ir in the ARC in adult female and male WT and ArKO mice treated with EB 0.05 g
from P15 to P25 (every day). All animals were gonadectomized in adulthood and treated with EB 1 g two weeks prior sacrifice. No significant
difference was found between all groups. The number of animals in each group is given in parentheses.
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kisspeptin protein expression was also recently observed
during the neonatal period, i.e., as early as P7 (23, 24, 37);
however, this sex difference persisted throughout postna-
tal development, puberty and adulthood. In mice, Clark-
son and colleagues (1, 3) detected kisspeptin-ir fibers at
different postnatal ages (P10 – P25 – P31 – P61) in the
ARC in WTmales and females, but did not show a quan-
tification of this expression.More recently, another study
showed that the kisspeptin-ir increased qualitatively in the
ARC in both WT female and male mice during develop-
ment, peaking at P45 (38). However, they claimed that
kisspeptin staining showed no appreciable differences be-
tweenmale and female ARC, although they did not quan-
tify it. In the present study, we showed an increase in kiss-
peptin protein expression in the female ARC from P10 to
P25 (even to P30, data not shown). The appearance of
kisspeptin cells and fibers in WT females between P5 and
P10 could coincide with the first sex steroid secretion by
the ovaries (39); however, ArKO females expressed sim-
ilar kisspeptin-ir levels at P10 than WT females although
they do not produce E2 due to their targeted mutation in
the aromatase gene. These data thus suggest that the ex-
pression of kisspeptin during early postnatal period in the
ARC is organized by E2-dependent and –independent
mechanisms. This hypothesis is also reinforced by the fact
that WT and ArKO males showed the same significant
increase in kisspeptin protein expression at P25. By using
the hypogonadal (hpg) mouse model which carries a large
deletion in the Gnrh1 gene resulting in a failure to syn-
thesize GnRH and thus in very low levels of gonadal ste-
roid hormones, Gill and colleagues (38) also showed that
at the ages of normal pubertal maturation kisspeptin-ir
was clearly detected in hpgmales and females despite the
absence of any appreciable exposure to sex steroids. Fur-
thermore, the hormone-independent increase of ARC
kisspeptin protein expression in ArKO and hpg mice is
also consistent with previous studies showing that central
mechanisms regulating the onset of puberty were not go-
nad dependent (40-42). According to Kiss1 mRNA stud-
ies, ARC kisspeptin expressing neurons were identified
from embryonic day 12 inmice (43, 44), but did not show
any developmental changes across the postnatal period
(45) and were present at very low levels at the prepubertal
period, i.e., from P16 to P18 (46). Furthermore, no sex
difference was ever observed regarding Kiss1mRNA lev-
els in the ARC between male and female mice. All these
data do not follow the same pattern as what we observed
in the present study. However, some reports concerning
unrelated changes betweenKiss1mRNAandkisspeptin-ir
levels already exist (25-27, 38) and notably suggest post-
transcriptional regulationsof theKiss1gene. For example,
kisspeptin-ir cells increased in the ARC in the female rat
between diestrus and proestrus phases whereas Kiss1
mRNA levels showed opposite fluctuations (26). Finally,
the sex difference in kisspeptin protein expression ob-
served in the present study could also result either from a
combination of lowerKiss1 transcription, or a lower kiss-
peptin synthesis and/or higher peptide release in males
compared to females. In support of this last hypothesis,
future studies should focus on kisspeptin-ir levels in the
ARC in colchicine-treated mice.
Effects of sex steroids on the AVPv/PeN kisspeptin
system during early postnatal development
As previously described (1, 3), we found no kisspeptin
protein expression before P15 in the AVPv/PeN and the
number of kisspeptin expressing cells increased at P25 in
females (data not shown). A strong sex difference was
already established between P15 and P25 whereas ArKO
males and females showed no kisspeptin expressing cells
across all postnatal ages. Our data thus confirm that the
major period of appearance of kisspeptin protein expres-
sion in the AVPv/PeN occurs over a 15 d time period be-
tween P15 and P30, and that reproductive hormones are
most likely required for the expression of kisspeptin dur-
ing early postnatal development in both females andmales
to establish the sexually dimorphic pattern observed in the
AVPv/PeN as already well studied (1, 3, 16, 38).
Interestingly, there seems to be some paradox when
comparing the first appearance of kisspeptin peptide ex-
pression in the AVPv/PeN versus the ARC. Previous study
(47) showed that projections from neurons in the AVPv/
PeN to theARCarewell-establishedbefore birth, but kiss-
peptin protein or mRNA is not expressed before birth. By
contrast, kisspeptin mRNA is already expressed at E12 in
the ARC (43, 44) although its protein probably not before
P5,whereas the projections from theARC to theAVPv are
not fully mature before P18 (48, 49). Since kisspeptin has
beenproposed toplay apredominant role in regulating the
pubertal and adult reproductive axis, the presence of kiss-
peptin in the ARC during early development remains un-
known. Does it play a specific role in establishing the pro-
jections from the AVPv to the ARC? Obviously more
research is needed on the ontogeny of kisspeptin in the
AVPv/PeN versus the ARC.
Effects of sex steroids on the ARC kisspeptin
system in adulthood
In contrast with the early postnatal period, sex differ-
ences in kisspeptin protein expression were abolished in
the adult ARC. This is in accordance with previous results
on Kiss1 mRNA expression (36). However, we showed
that gonadectomy decreased kisspeptin peptide expres-
sion in the ARC of both sexes whereas E2 or DHT short-
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term treatment (10 d) restored kisspeptin peptide expres-
sion in gonadectomized males and females. This reflects
opposite effects compared to the modulation of Kiss1
mRNA levels by sex steroids in theARC in adulthood (10,
11, 36). This discrepancy could be explained by the fact
that: 1/ the source of kisspeptin fibers revealed by the ICC
is still not identified, as they could originate from theARC
but also from the AVPv/PeN (47) and/or even from the
MeA (48); 2/ a reduced fiber staining could represent ei-
ther increased kisspeptin secretion/release or increased
storage/decreased transport. It is thus difficult to interpret
what the changes in fiber levels reflect in terms of kiss-
peptin function.
We also observed that a long-term (6 wk) E2 treatment
totally suppressed kisspeptin peptide expression in ovari-
ectomized WT and ArKO females whereas a short-term
(10 d) E2 treatment restored WT-like levels of kisspeptin
peptide expression in these animals. After 6 wk of E2 ex-
position, the HGP axis might have been overstimulated
resulting in an increase of the turnover of the kisspeptin
peptide secretion, which could thus be not detected by
using immunohistochemistry.
Finally, we showed that DHT treatment had the same
effects as E2 treatment, which is in accordance to previous
findings showing that DHT, as T and E2, decreased Kiss1
mRNA levels in theARC (11).However, it is important to
note that a metabolite of DHT, such as 5alpha-
androstane,3beta,17beta-diol (3beta-Diol) can act as an
estrogenic compound by activating the ER pathway (49,
50). Thus, the stimulatory effects of DHT on kisspeptin
protein expression in the ARC might not imply the an-
drogen receptor pathway (as previously suggested by
(11)), but only the ER pathway.
Effects of sex steroids on the AVPv/PeN kisspeptin
system in adulthood
As observed in the early postnatal period (data not
shown), a sex difference in kisspeptin peptide expression
was also present in adulthood, with intact WT females
showing more kisspeptin expressing cells compared to in-
tact WT males. This fits with the theory that the AVPv/
PeNkisspeptin population is required for the regulationof
the preovulatory surge of gonadotropins observed in fe-
males (3, 51). We also showed that long-term gonadec-
tomy strongly decreased kisspeptin peptide expression in
WT females whereas E2 treatment, but not DHT, in-
creased the number of kisspeptin expressing cells. This is
completely in accordance with previous results on Kiss1
mRNA expression (10, 11, 36). Intact ArKOmice of both
sexes showed a low, “male-typical” expression of kiss-
peptin in the AVPV/PeN suggesting thus that perinatal E2
exposure is required for the full development of theAVPv/
PeN kisspeptin population. This hypothesis was rein-
forced by the fact that E2 treatment increased kisspeptin
protein expression inadult ovariectomizedArKOfemales,
but failed to restore it toWT-like levels.More surprisingly,
adult gonadectomized ArKO males treated with E2 also
showed an increase in the number of kisspeptin expressing
cells whereas gonadectomized WT males did not. This
could mean that the AVPv/PeN kisspeptin neuronal pop-
ulation in ArKO males was not completely defeminized
(and as a result could be still stimulated following exog-
enous E2 treatment) due to an absence of E2 exposure
during the perinatal period.
Critical period for development of the two
different kisspeptin populations
In the present study, we showed that the ARC kisspep-
tin populationwas not affected in adulthood followingEB
treatment either between P5-P15 or P15-P25 in either sex
or genotype. This suggests that the ARC kisspeptin pop-
ulation is regulated by sex steroids or others factors during
another critical period such as puberty or the perinatal
period. Recent data in rats showed that kisspeptin-ir cells
were first detected in the embryonic ARC at E14.5 and
increased until E18.5; then the number of kisspeptin-ir
cells strongly decreased until birth (21). In mice, ARC
Kiss1mRNA levels were detected from E12 (43, 44), but
future studies have to be conducted to determine the spa-
tio-temporal appearance of kisspeptin protein expression
in mouse embryos of both sexes.
In the AVPv/PeN, treatment of WT females with EB
over the early postnatal period (P5-P15) defeminized the
kisspeptin neuronal population in adulthood whereas the
same treatment administered over a prepubertal period
(P15 to P25) had not such an effect. However, this par-
ticular prepubertal EB treatment partially restored the
AVPv/PeN kisspeptin population in adulthood in ArKO
females. Our data thus suggest that the AVPv/PeN kiss-
peptin population could be still defeminized/masculinized
at P5 and perhaps until P10 and is feminized from P15
onwards, which is in accordance with previous experi-
ences regarding to the expression of sexual behaviors (28).
Prepubertal treatment with EBalso increased the number
of kisspeptin-ir cells in ArKOmales, but not in WTmales
suggesting that these neurons still kept the capacity to
respond toE2 and thusbe feminized.Taken together, these
observations suggest that the increase inT (and conversely
E2) occurring in male rodents during the perinatal period
is responsible for the dampening of AVPv/PeN kisspeptin
expressing neurons whereas the complete functional fem-
inization of the AVPv/PeN kisspeptin population is not a
merely passive process as was previously suggested (8, 13)
but requires the active contribution of some estrogenic
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inputs. In mice, Clarkson and colleagues (3) showed that
replacement of E2 in P15-ovariectomized females from
P15-P30 or P22-P30 resulted in a complete restoration of
kisspeptin peptide expression in AVPv/PeN; however,
they used a higher dose of E2 (Silastic capsules) and killed
their animals directly after the E2 treatment, i.e., at P30. In
adult rats, a strong decrease of AVPv/PeN kisspeptin-ir
fibers was observed following exposure to EB or phytoes-
trogens (52), ER (PPT; (53)) orER (DPN; (54)) agonists
from P0 to P3. However, a decrease in ARC kisspeptin-ir
fibers was also observed after EB exposure from P0 to P3,
suggesting species-specific differences compared to our
study.
Conclusions
By using immunohistochemical studies, we showed here
that the two kisspeptin neuronal populations, i.e., AVPv/
PeN and ARC are very plastic systems which are modu-
latedby sex steroids frombirth toadulthood.Weobserved
for the first time a clear sex difference in the development
of the ARC kisspeptin neuronal population with females
showing more kisspeptin-ir from P5 to P30 compared to
males. Furthermore, we demonstrated that the ARC kiss-
peptin system seems to be organized by E2-dependent and
–independent mechanisms since ArKO animals showed
significant levels of kisspeptin-ir. In adulthood, sex ste-
roids, i.e., E2 and DHT, differentially activate the two
kisspeptin neuronal populations. Finally, we showed that
the AVPv/PeN kisspeptin system could be still masculin-
ized at postnatal day 5, and was feminized from postnatal
day 15 onwards showing that E2 can have both mascu-
linizing and feminizing effects on the kisspeptin system
depending on when during development it is present.
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